Estados Unidos · Revistas de economía · Quartz

Apothecary Pharma is recalling 22 vials of weight loss drug over sterility concerns

Publicado por Quartz · Estados Unidos hace 2 h

The company received an FDA warning letter in December 2025 citing deficiencies in how it makes sterile drug products

Leer el artículo completo en Quartz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (qz.com)

También te puede interesar

The Hidden Costs of Covered-Call ETFs

No wonder the White House wants Warsh to cut: A 1% Fed rate hike costs the Treasury an extra $95 billion a year in national debt interest

Alexa von Tobel’s Inspired Capital Backed 10 Unicorns. Its New $450 Million Fund Targets 1 Kind of Founder

‘You Can See Everything’ perfectly captures what a decade of post-truth has done to us

Millennials Are Satisfied At Work Because They Stopped Expecting More

Take your drinks on a bus to the Chiefs game